it may also be used as part of post exposure prophylaxis to prevent hiv infection following potential exposure it is taken by mouth common side effects include trouble sleeping feeling tired nausea high blood sugar and headaches severe side effects may include allergic reactions including stevens johnson syndrome muscle breakdown and liver problems it is unclear if use during pregnancy or breastfeeding is safe raltegravir is an hiv integrase strand transfer inhibitor which blocks the functioning of hiv integrase which is needed for viral replication raltegravir was approved for medical use in the united states in 2007 it is on the world health organization s list of essential medicines the most effective and safe medicines needed in a health system the wholesale cost in the developing world is about 50 usd per month in the united kingdom it costs the nhs about 472 00 pounds per month lamivudine raltegravir a combination with lamivudine is also available raltegravir was initially approved only for use in individuals whose infection has proven resistant to other haart drugs however in july 2009 the fda granted expanded approval for raltegravir for use in all patients as with any haart medication raltegravir is unlikely to show